Image of Jennifer J. Furin

Jennifer J. Furin, M.D., Ph.D.

Jennifer Furin, MD, PhD, is an infectious diseases clinician and a medical anthropologist who focuses on global health. She received her PhD in Medical Anthropology from the University of California at Los Angeles in 1995 and her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women’s Hospital in 2002 and her fellowship in infectious diseases at University Hospitals Case Medical Center (Cleveland) in 2004. Dr. Furin is engaged in clinical and program work and operational research to support the treatment of multidrug-resistant tuberculosis and HIV. She has been fighting drug-resistant TB since 1995 when she began working in Lima, Peru with Partners In Health. She has significant global experience and has done work in Haiti, Peru, Russia, Lesotho, South Africa, Georgia, Bangladesh, Swaziland, and Tajikistan. She is also a member of the Tuberculosis Transformation Science Committee of the AIDS Clinical Trials Group. She serves as a high-level consultant for a number of National TB Programs, WHO, USAID, and Médecins Sans Frontières

Affiliations:

Dr. Furin is also an adjunct assistant professor in the Department of Anthropology at Case Western Reserve University

Dr. Furin is the director of Clinical Capacity Building for the Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Dr. Furin is participating in teaching and research in the Department's Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Compassionate and optimum use of new tuberculosis drugs.
Authors: Authors: Reed C, Mason L, Cox H, Seaworth B, Lessem E, Furin J.
Lancet Infect Dis
View full abstract on Pubmed
In reply. QTc prolongation and delamanid: access and safety.
Authors: Authors: Furin J, Harausz E, Zimetbaum P, Cox H.
Int J Tuberc Lung Dis
View full abstract on Pubmed
The need to accelerate access to new drugs for multidrug-resistant tuberculosis.
Authors: Authors: Cox HS, Furin JJ, Mitnick CD, Daniels C, Cox V, Goemaere E.
Bull World Health Organ
View full abstract on Pubmed
Programmatic management of children with drug-resistant tuberculosis: common sense and social justice.
Authors: Authors: Monedero I, Furin J.
Public Health Action
View full abstract on Pubmed
Informed use of bedaquiline for tuberculosis.
Authors: Authors: Furin J.
Lancet
View full abstract on Pubmed
QTc prolongation and treatment of multidrug-resistant tuberculosis.
Authors: Authors: Harausz E, Cox H, Rich M, Mitnick CD, Zimetbaum P, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Getting it right for children: improving tuberculosis treatment access and new treatment options.
Authors: Authors: Brigden G, Furin J, Van Gulik C, Marais B.
Expert Rev Anti Infect Ther
View full abstract on Pubmed
Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives.
Authors: Authors: Lessem E, Cox H, Daniels C, Furin J, McKenna L, Mitnick CD, Mosidi T, Reed C, Seaworth B, Stillo J, Tisile P, von Delft D.
Int J Infect Dis
View full abstract on Pubmed
The 'invisibility' of children with tuberculosis.
Authors: Authors: McKenna L, Frick M, Seaworth B, Furin J.
J Public Health Policy
View full abstract on Pubmed
Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
Authors: Authors: Benbaba S, Isaakidis P, Das M, Jadhav S, Reid T, Furin J.
PLoS One
View full abstract on Pubmed